Guleria, A S <br/><br/>
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 1994 
 - 2714-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.12.2714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Blood Urea Nitrogen<br/>Carcinoma, Renal Cell--secondary<br/>Child<br/>Creatinine--blood<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Kidney Diseases--blood<br/>Kidney Neoplasms--pathology<br/>Male<br/>Melanoma--secondary<br/>Middle Aged<br/>Skin Neoplasms--pathology